Symmetry Partners, LLC Merck & Co., Inc. Transaction History

Symmetry Partners, LLC

$422 Million
Q3 2024

A detailed history of Symmetry Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Symmetry Partners, LLC holds 3,920 shares of MRK stock, worth $399,369. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,920

Previous 11,786 66.74%

Holding current value

$399,369

Previous $1.46 Million 69.5%

% of portfolio

0.11%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$111.15 - $128.97 $874,305 - $1.01 Million	-7,866 Reduced 66.74%	3,920 $445,000
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $119,838 - $128,705	-968 Reduced 7.59%	11,786 $1.46 Million
Q1 2024 Apr 02, 2024	SELL	$113.24 - $131.95 $1.56 Million - $1.81 Million	-13,754 Reduced 51.89%	12,754 $1.68 Million
Q4 2023 Jan 02, 2024	SELL	$100.18 - $109.02 $4.22 Million - $4.59 Million	-42,084 Reduced 61.35%	26,508 $2.88 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $1.35 Million - $1.5 Million	-13,143 Reduced 16.08%	68,592 $7.06 Million
Q2 2023 Jul 05, 2023	SELL	$108.61 - $118.38 $47,028 - $51,258	-433 Reduced 0.53%	81,735 $9.43 Million
Q1 2023 Apr 03, 2023	BUY	$102.94 - $114.86 $717,388 - $800,459	6,969 Added 9.27%	82,168 $8.74 Million
Q4 2022 Jan 06, 2023	BUY	$87.44 - $112.11 $418,575 - $536,670	4,787 Added 6.8%	75,199 $8.34 Million
Q3 2022 Oct 03, 2022	SELL	$84.53 - $94.96 $3,803 - $4,273	-45 Reduced 0.06%	70,412 $6.06 Million
Q2 2022 Jul 11, 2022	BUY	$83.49 - $94.64 $4.81 Million - $5.45 Million	57,601 Added 448.05%	70,457 $6.42 Million
Q1 2022 Apr 04, 2022	BUY	$73.51 - $82.4 $230,012 - $257,829	3,129 Added 32.17%	12,856 $1.06 Million
Q4 2021 Jan 11, 2022	SELL	$72.28 - $90.54 $177,375 - $222,185	-2,454 Reduced 20.15%	9,727 $745,000
Q2 2021 Jul 07, 2021	BUY	$70.31 - $77.77 $8,648 - $9,565	123 Added 1.02%	12,181 $947,000
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $1.4 Million - $1.65 Million	-20,348 Reduced 62.79%	12,058 $930,000
Q4 2020 Feb 18, 2021	SELL	$71.77 - $79.65 $78,301 - $86,898	-1,091 Reduced 3.26%	32,406 $2.65 Million
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $1.38 Million - $1.56 Million	18,861 Added 128.87%	33,497 $2.78 Million
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $1.03 Million - $1.17 Million	14,636 New	14,636 $1.13 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $1.49 Million - $2.06 Million	-23,444 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $780,377 - $880,564	-10,059 Reduced 30.02%	23,444 $2.13 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $84,506 - $98,723	-1,210 Reduced 3.49%	33,503 $2.81 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $1.03 Million - $1.18 Million	14,863 Added 74.88%	34,713 $2.89 Million
Q4 2018 May 22, 2019	BUY	$65.24 - $75.71 $1.3 Million - $1.5 Million	19,850 New	19,850 $1.52 Million

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.

Account

Symmetry Partners, LLC Merck & Co., Inc. Transaction History